Highlights Ardelyx, Inc.

Equities

ARDX

US0396971071

Real-time Estimate Cboe BZX Other stock markets 12:18:39 2024-07-03 pm EDT			5-day change	1st Jan Change
5.285 ^USD	+0.09%		-14.09%	-15.33%

04:50pm	HC Wainwright Adjusts Ardelyx's Price Target to $10 From $13, Keeps Buy Rating	MT
Jul. 02	Piper Sandler Downgrades Ardelyx to Neutral From Overweight, Cuts Price Target to $7 From $15; Shares Plunge	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sector Update: Health Care Stocks Lean Lower Premarket Tuesday	Jul. 02	MT
Sector Update: Health Care	Jul. 02	MT
Ardelyx, Inc. Chooses Not to File for TDAPA to Preserve Patient Access to XPHOZAH	Jul. 02	CI
Ardelyx Shares Rise After Q1 Beat	May. 03	MT
Top Premarket Gainers	May. 03	MT
Earnings Flash (ARDX) ARDELYX Reports Q1 Revenue $46M, vs. Street Est of $36.4M	May. 02	MT
Ardelyx, Inc. Provides IBSRELA Revenue Guidance for the Full Year 2024	May. 02	CI
Ardelyx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
Ardelyx's Q4 Swings to Loss; Revenues Down; Shares Down After-Hours	Feb. 23	MT
Ardelyx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
Ardelyx, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22	CI
Earnings Flash (ARDX) ARDELYX Posts Q4 Revenue $34.4M, vs. Street Est of $34.2M	Feb. 22	MT
ARDELYX INC: JEFFERIES RAISES TARGET PRICE TO $11 FROM $8…	Jan. 09	RE
Ardelyx Provides Update On 2024 Strategic Priorities	Jan. 08	RE
Ardelyx, Inc. Announces XPHOZAH(R) Now Available in the United States	Nov. 06	CI
Ardelyx Shares Positive Data from Studies of Xphozah®? At Asn Kidney Week 2023	Nov. 03	CI
Earnings Flash (ARDX) ARDELYX Reports Q3 Revenue $56.4M, vs. Street Est of $22.6M	23-10-31	MT
Ardelyx, Inc. Provides Earnings Guidance for the Full Year 2023	23-10-31	CI
Ardelyx, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-31	CI
Ardelyx, Inc. Shares Positive Data on Symptom Response During Treatment with IBSRELA®? for IBS-C and Hosts IBS-C Product Theater at ACG 2023	23-10-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Ardelyx, Inc.

Equities

ARDX

US0396971071

Highlights

Filters